Visalytics
Visalytics
approved EB-2 (NIW)

Graduate Researcher

Chemistry · Pakistan · 2025-12-17

Processing Time
26 days
Decision Date
2025-12-17
Location
Canada
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to design and synthesize novel tin- and copper-based organometallic complexes and characterize their structures using advanced spectroscopic and crystallographic methods. The work integrates computational modeling with biological evaluation to establish structure–activity relationships for developing safer, more selective metal-based anticancer therapies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research supports national efforts to improve cancer treatment outcomes and reduce toxicity in chemotherapy.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a solid record of academic achievement including 9 journal articles and 80 citations.

3 Balance of Interests Met

The petitioner's specialized research in chemistry is clearly connected to national healthcare priorities, making a waiver beneficial to the United States.

Why This Petition Was Approved

The petition was approved based on the petitioner's M.Phil. in Chemistry and a record of 9 peer-reviewed journal articles, including 1 first-authored publication. The evidence included 80 citations and documentation of 3 completed peer reviews, satisfying all three prongs of the Dhanasar framework.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Scientist

Pharmaceuticals · New Zealand

WeGreened EB-2 (NIW) approved
California 467 days 2025-03-05
The petitioner proposes to design and optimize novel small-molecule therapeutics to improve cancer patient outcomes, specifically targeting difficult-to-treat cancers. Their work involves leveraging synthetic organic chemistry and catalysis to develop innovative approaches for constructing biologically active lead compounds with enhanced pharmacological profiles.
View Case

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Michigan 655 days 2025-08-08
The petitioner proposes to develop new material characterization techniques to synthesize and describe novel materials for use in biomaterials and therapeutics. Her work focuses on innovative nanocomposite synthesis with large surface area and biocompatibility for drug delivery, wound healing, and anti-pathogen coatings. Additionally, she aims to study novel chemical derivatives to lay the groundwork for future treatments for Alzheimer’s disease.
View Case

Scientist

Pharmaceuticals · Bangladesh

WeGreened EB-2 (NIW) approved
Massachusetts 69 days 2022-04-19
The petitioner proposes to continue analyzing synthetic routes to isolate, synthesize, design, and ensure the safety of novel drug molecules. This work is part of innovative drug discovery projects aimed at treating cancer, heart disease, and infectious diseases to improve global and U.S. healthcare outcomes.
View Case

Scientist

Biotechnology · Nepal

WeGreened EB-2 (NIW) approved
Arkansas 14 days 2025-02-20
The petitioner proposes to synthesize novel engineered nanoplatforms for therapeutic applications and develop non-cell culture-based efficacy determination methods for targeting therapeutic nanomaterials. The work aims to create cancer treatments with high specificity to improve treatment effectiveness while reducing off-target effects.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from Pakistan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-12-17.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 26 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Pakistan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist